Cipta Sarana Medika Tbk. vs Kimia Farma Tbk — how do they compare? Cipta Sarana Medika Tbk. trades at Rp63 (market cap 158.12B, 8.21M 24h volume), while Kimia Farma Tbk trades at Rp454 (market cap 2.53T, 414.5K 24h volume). The key difference: Kimia Farma Tbk is far larger — about 16× Cipta Sarana Medika Tbk.'s market cap, and Cipta Sarana Medika Tbk. is more actively traded (8.21M versus 414.5K). Which is the better fit depends on your goals.
| DKHH | KAEF | |
|---|---|---|
Market Cap | 158.12B | 2.53T |
Volume | 8.21M | 414.5K |
Lot | 82.15K | 4.15K |
Turnover | 515.2M | 187M |
Average Price | 62.72 | 451.15 |
Value | 515.2M | 187M |
Indicative Equilibrium Price | 63 | 454 |
Indicative Equilibrium Volume | 1.33K | 50 |
Trailing returns across standard periods
Latest headlines on both assets
PT Cipta Sarana Medika Tbk (the Company) was established based on Deed No. 90 dated September 17, 2014 by Dede Fujianti, SH., M.Kn., Notary in Sukabumi. The Company ultimate parent entity is PT Siliwangi Djajakusumah Bersatu. The Company started its commercial operations in 2014.
Read more on DKHH →PT Kimia Farma Tbk (the Company) was established based on the Notarial Deed No. 18 dated August 16, 1971, as amended by Notarial Deed No. 18 dated October 11, 1971 of Soelaeman Ardjasasmita, S.H., under its original name Perusahaaan Negara Farmasi dan Alat Kesehatan Bhinneka Kimia Farma (PN Farmasi Kimia Farma). PN Farmasi Kimia Farma consist of : Badan Pimpinan Umum Perusahaan-perusahaan Negara Farmasi dan Alat Kesehatan (established 1961) Perusahaan Negara Farmasi Alat Kesehatan Radja Farma (established 1961) Perusahaan Negara Farmasi Alat Kesehatan Nakula Farma (established 1961) Perusahaan Negara Farmasi Alat Kesehatan Bhinneka Kimia Farma (established 1961)PN Farmasi Kimia Farma has been changed to PT Kimia Farma (Persero) Tbk based on notarial deed dated October 11, 1971. The company’s article of association has been amended from time to time, the latest of which was covered by notarial deed dated Sept 22, 2000 by Wahjono H, SH concerning Right Issue (as public company). The Company operates 210 apoteks, 6 units production and 40 branches pharmacy wholesale. The company’s share will be listed in BEJ and BES.
Read more on KAEF →